Abstract
The growing interest in ocular drug delivery systems is driven by the advantages of nanoparticles in drug administration, including sustained release and reduced side effects. Hyaluronic acid (HA) is promising both for the fabrication of nanoparticles due to its biocompatibility and bioadhesion properties and for imparting therapeutic properties by interacting with CD44 receptors in ocula…